Satellite Symposia

A number of slots were set aside by the Scientific Programme Committee for company sponsored satellite sessions.

All delegates were invited to attend the company sponsored satellite symposia. The programmes for these satellite symposia were designed by the sponsoring companies and vetted by the ECTS Scientific Programme Committee to ensure balance, independence, objectivity and scientific rigour.

Saturday 17 May 15:15 - 16:45
Congress Hall
MSD Satellite Symposium

Chair: Ian Reid (New Zealand)

  • Welcome & opening
    Ian Reid
  • Long-term treatment of osteoporosis: The Risk Benefit Equation
    Erik Eriksen
  • Effects of osteoporosis agents on bone strength
    Mary Bouxsein
  • Opportunities for new osteoporosis therapies
    Ian Reid
  • Q&A Panel

Sunday 18 May 12:30 - 14:00
Panorama Hall
Alexion Satellite Symposium
New perspectives in rare bone disorders: HPP – what you need to know

Chair: Professor Nick Bishop (UK)

  • Introduction
    Professor Nick Bishop (UK)
  • Characterising ALP – a critical enzyme in bone mineralisation
    Professor José Luis Millán (USA)
  • HPP: a wide-ranging disease with variable presentation
    Dr Christine Hofmann (Germany)
  • Panel discussion
    All
  • Conclusion
    Professor Nick Bishop (UK)

Monday 19 May 12:30 - 14:00
Panorama Hall
Amgen Satellite Symposium
Current challenges in the management of osteoporosis therapy

Chairs: Bente Langdahl (Aarhus, Denmark)
           Jan Štepan, Prague (Czech Republic)

  • Welcome and introduction
  • Prioritising the treatment needs in postmenopausal osteoporosis
    Kristina Åkesson (Malmö, Sweden)
  • Long-term treatment with denosumab: Which patients benefit the most?
    Christian Roux (Paris, France)
  • Treating postmenopausal osteoporosis: What makes the difference?
    Roland Baron (Boston, USA)
  • Panel discussion